News
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
Week Low Stocks to Buy Right Now. On June 26, Merck & Co., Inc. (NYSE:MRK) announced that the Advisory Committee on Immunization Practices has approved ENFLONSIA for preventing respiratory syncytial ...
Immunizations “are not all good or bad,” says the chair of the overhauled panel.
The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...
The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.
Although the U.S. CDC’s Advisory Committee for Immunization Practices (ACIP) was scheduled to vote June 25 on recommendations ...
The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...
The letter, signed by 79 medical societies, expresses concern over recent federal immunization review policies and asks that ...
10don MSN
The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results